New products

Mobile ECG system delivers beat-by-beat data

Everist Genomics announced it’s commercializing its CardioDefender diagnostic system, a smartphone ECG that can provide continuous readings throughout the day that can help detect arrhythmias that may be hard to spot in an office visit. The system uses a wrist watch-like device to collect data from electrodes and transmit it wirelessly via Bluetooth to a smartphone that can then share it with clinicians monitoring the patient.

CardioDefender delivers mobile, real-time, beat-by-beat, and quantitative heart monitoring and automated reporting by combining patented analytical smartphone software with a Bluetooth device and electrodes. The electrodes, which are attached to the patient’s skin, transmit heart rhythm data to the Bluetooth device, which then transmits the data to the smartphone. The smartphone software analyzes the heart rhythm data, and the data is sent to a cardiac monitoring center which keeps an encrypted record of the data that can be reviewed by physicians.

Physicians are also able to receive arrhythmia alerts via their smartphone, tablet, laptop or desktop computer. In the event of a significant arrhythmia, the CardioDefender system will automatically transmit an alert to the patient’s physician while the event is occurring.

CardioDefender, which recently won both FDA approval and EU’s CE Mark, can activate an alarm to rapidly notify a physician of any particularly unwelcome graph via an email, page, or other electronic means.

A fully mobile system, CardioDefender delivers hospital-based quality ECG and arrhythmia analysis by integrating unique software, algorithms and data compression capabilities which enable a smartphone to perform as a mobile ECG.

Features include:

• Real-time, heart-rhythm monitoring;

• Beat-by-beat analysis of heart rhythm (as opposed to sampling some heart beats or part of a heart beat);

• Long term monitoring capability – CardioDefender can perform up to 3 months of real-time, beat-by-beat quantitative patient monitoring and analysis;

• Quantitative analysis and reporting – CardioDefender is a fully automated, quantitative ECG monitoring and arrhythmia event reporting system;

• Comprehensive range of heart rhythm monitoring algorithms to enable automated detection and reporting of medically important arrhythmias to physicians and monitoring centers;

• Abnormal heart rhythms reported directly to a physician’s mobile phone or computer – innovative and patent protected software and data compression technology means CardioDefender can report real-time results to a physician’s smartphone, tablet, laptop and desk top computer (in addition to a cardiac monitoring center);

• Access to full, detailed ECG data captured during the monitoring period, including post heart monitoring data processing for additional measurements; and

• Real-time reporting of symptomatic and asymptomatic arrhythmias – CardioDefender has the ability to capture and report both symptomatic and asymptomatic arrhythmias.

For more information, visit www.everistgenomics.com

Posted November 24, 2011